Xie Shuang (谢爽)
* graduated from
Zhejiang University in ~1987 and got her PhD from Queen’s University in Canada in 1993
* former Director and Chief Technology Advisor of Abattis Bioceuticals
* Controlling shareholder of Hangzhou Aibeida; its subsidiary CBD99 Inc leased a 5,000 sq ft facility at Firwood Industrial Park, Sandy, Oregon and obtained a Hemp Handling License from the Oregon Department of Agriculture in Aug 2018.
“Canadian prosecutors have quietly dropped charges against a Chinese scientist in Vancouver accused of importing more than 100 kilograms of a narcotics precursor, raising serious questions about her connections to Chinese academic programs and networks suspected of links to espionage, foreign interference, and transnational crime ...
The 57-year-old chemist, referred to here as Dr. X due to the unusual termination of the case, has documented affiliations with Chinese institutions flagged for military research and intelligence collaboration. According to filings from a bio-pharmaceutical company with ties to the University of British Columbia that hired her to lead large-scale cannabinoid extraction, Dr. X was reportedly working within Canadian universities under Beijing’s “Talents” plan—a recruitment initiative expanded under President Xi Jinping and described by U.S. intelligence as a platform for espionage and dual-use technology transfer.
British Columbia court records confirm that Dr. X, a graduate of Zhejiang University — an institution associated with China’s Ministry of State Security — was charged in June 2022 with importing and exporting a controlled substance.
Sources familiar with the court file informed The Bureau that Dr. X was accused of importing over 100 kilograms of PMK ethyl glycidate, a synthetic chemical widely used in the production of MDMA (ecstasy). Dr. X was allegedly caught retrieving the shipment in Richmond, British Columbia.”
thebureau.news/p/exclusive-ch
newsfilecorp.com/release/23515/
accessnewswire.com/newsroom/en/he
newswire.ca/news-releases/
newswire.ca/news-releases/